CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Shares	Additional paid-in capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		143,833
Beginning balance at Dec. 31, 2023	$ 377,954	$ 1,200,218	$ 120,788	$ (730)	$ (942,322)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(2,374)
Purchases of common shares under Share Repurchase Plan	(13,370)	$ (13,370)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		2,231
Issuance of common shares from exercise of stock options and vesting of RSUs	28	$ 21,134	(21,106)
Shared-based compensation	5,737		5,737
Unrealized loss on available-for-sale securities	(124)			(124)
Net income (loss)	(10,749)				(10,749)
Ending balance (in shares) at Mar. 31, 2024		143,690
Ending balance at Mar. 31, 2024	359,476	$ 1,207,982	105,419	(854)	(953,071)
Beginning balance (in shares) at Dec. 31, 2023		143,833
Beginning balance at Dec. 31, 2023	377,954	$ 1,200,218	120,788	(730)	(942,322)
Increase (Decrease) in Stockholders' Equity
Net income (loss)	(10,027)
Ending balance (in shares) at Jun. 30, 2024		142,984
Ending balance at Jun. 30, 2024	364,616	$ 1,205,554	112,270	(859)	(952,349)
Beginning balance (in shares) at Mar. 31, 2024		143,690
Beginning balance at Mar. 31, 2024	359,476	$ 1,207,982	105,419	(854)	(953,071)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(1,050)
Purchases of common shares under Share Repurchase Plan	(5,249)	$ (5,249)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		192
Issuance of common shares from exercise of stock options and vesting of RSUs	383	$ 1,773	(1,390)
Issuance of common shares under ESPP (in shares)		152
Issuance of common shares under ESPP	703	$ 1,048	(345)
Shared-based compensation	8,586		8,586
Unrealized loss on available-for-sale securities	(5)			(5)
Net income (loss)	722				722
Ending balance (in shares) at Jun. 30, 2024		142,984
Ending balance at Jun. 30, 2024	$ 364,616	$ 1,205,554	112,270	(859)	(952,349)
Beginning balance (in shares) at Dec. 31, 2024	140,883	140,883
Beginning balance at Dec. 31, 2024	$ 377,478	$ 1,187,696	126,999	(647)	(936,570)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(5,807)
Purchases of common shares under Share Repurchase Plan	(47,400)	$ (47,400)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		2,671
Issuance of common shares from exercise of stock options and vesting of RSUs	355	$ 22,966	(22,611)
Shared-based compensation	(3,409)		(3,409)
Unrealized loss on available-for-sale securities	(178)			(178)
Net income (loss)	23,344				23,344
Ending balance (in shares) at Mar. 31, 2025		137,747
Ending balance at Mar. 31, 2025	$ 350,190	$ 1,163,262	100,979	(825)	(913,226)
Beginning balance (in shares) at Dec. 31, 2024	140,883	140,883
Beginning balance at Dec. 31, 2024	$ 377,478	$ 1,187,696	126,999	(647)	(936,570)
Increase (Decrease) in Stockholders' Equity
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)	227
Net income (loss)	$ 44,857
Ending balance (in shares) at Jun. 30, 2025	132,668	132,668
Ending balance at Jun. 30, 2025	$ 335,301	$ 1,122,582	105,337	(905)	(891,713)
Beginning balance (in shares) at Mar. 31, 2025		137,747
Beginning balance at Mar. 31, 2025	350,190	$ 1,163,262	100,979	(825)	(913,226)
Increase (Decrease) in Stockholders' Equity
Purchases of common shares under Share Repurchase Plan (in shares)		(5,352)
Purchases of common shares under Share Repurchase Plan	(43,362)	$ (43,362)
Issuance of common shares from exercise of stock options and vesting of RSUs (in shares)		190
Issuance of common shares from exercise of stock options and vesting of RSUs	1,199	$ 2,062	(863)
Issuance of common shares under ESPP (in shares)		83
Issuance of common shares under ESPP	401	$ 620	(219)
Shared-based compensation	5,440		5,440
Unrealized loss on available-for-sale securities	(80)			(80)
Net income (loss)	$ 21,513				21,513
Ending balance (in shares) at Jun. 30, 2025	132,668	132,668
Ending balance at Jun. 30, 2025	$ 335,301	$ 1,122,582	$ 105,337	$ (905)	$ (891,713)